XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Operating activities          
Net Income (Loss) Attributable to Parent $ (23,966) $ 6,267 $ (33,866) $ (86,985)  
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]          
Credit loss expense     1,153 949  
Depreciation and amortization     19,765 30,695  
Amortization of financing costs charged to interest expense     1,234 1,192  
Amortization of right-of-use assets     2,807 4,230  
Stock-based compensation expense     29,956 32,194  
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability     15,044 114,144  
Other non-cash expense (income), net     (613) 10,524  
Change in operating assets and liabilities:          
Accounts receivable     10,991 15,082  
Prepaid expenses and other assets     1,114 (456)  
Accounts payable     (265) 111  
Increase (Decrease) in Accrued Liabilities     (10,282) (5,814)  
Partner Share liability     (4,994) (5,836)  
Consumer Incentive liability     (5,075) (4,248)  
Net cash used in operating activities     (3,119) (40,803)  
Investing activities          
Acquisition of property and equipment     (393) (1,090)  
Acquisition of patents     0 (73)  
Capitalized software development costs     (8,302) (9,170)  
Business acquisitions, net of cash acquired     0 (2,274)  
Net cash used in investing activities     (8,695) (12,607)  
Financing activities          
Proceeds from Issuance of Debt     30,000 0  
Payment for Contingent Consideration Liability, Financing Activities     50,050 0  
Principal payments of debt     (21) (24)  
Proceeds from issuance of common stock     55 397  
Payments of Stock Issuance Costs     (58) 0  
Net cash used in financing activities     (20,074) (39,808)  
Effect of exchange rates on cash, cash equivalents and restricted cash     43 (1,756)  
Net decrease in cash, cash equivalents and restricted cash     (31,845) (94,974)  
Cash, cash equivalents, and restricted cash — Beginning of period     121,985 233,562 $ 233,562
Cash, cash equivalents, and restricted cash — End of period 90,140 138,588 90,140 138,588 121,985
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet:          
Cash and cash equivalents 90,067 138,514 90,067 138,514 121,905
Restricted cash 73 74 73 74  
Total cash, cash equivalents and restricted cash — End of period 90,140 138,588 90,140 138,588 121,985
Supplemental schedule of non-cash investing and financing activities:          
Cash paid for interest     2,958 2,358  
Common stock purchase consideration for acquisition of Entertainment     0 11,937  
Payments of Debt Issuance Costs     0 181  
Increase (Decrease) in Income Taxes     0 (1,446)  
Goodwill impairment $ 0 $ 0 0 83,149 $ 396,200
Payments for Repurchase of Common Stock     $ 0 $ 40,000